<DOC>
	<DOCNO>NCT00957788</DOCNO>
	<brief_summary>This research study involve experimental drug ( NST_001 ) delivery system . The main purpose research study investigate safety NST-001 , deliver directly inner ear treatment tinnitus .</brief_summary>
	<brief_title>Safety Study NST-001 Neuroject Injection Set Treat Tinnitus</brief_title>
	<detailed_description />
	<mesh_term>Tinnitus</mesh_term>
	<criteria>Patients able provide voluntary consent . Severe tinnitus one ear begin ten year ago . Ear treat must deaf profound hearing loss . Subjects cardiac disease hypertension , must stable disease least 6 month . Subject must intact cochlear nerve ear treat . Women childbearing potential ( i.e. , postmenopausal surgically sterilize ) must agree use adequate birth control method recommend study physician . Current diagnosis bilateral tinnitus . Current diagnosis history pancreatitis . Females pregnant lactating . Use investigational drug within previous 30 day . History drug dependency substance abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>tinnitus</keyword>
	<keyword>acouphenes</keyword>
	<keyword>ear</keyword>
	<keyword>ring</keyword>
	<keyword>buzzing</keyword>
	<keyword>roar</keyword>
	<keyword>hiss</keyword>
	<keyword>click</keyword>
</DOC>